Skip directly to content

Committed to increasing blood cancer awareness

It's Blood Cancer Awareness Month


This September is Blood Cancer Awareness Month, which marks an important opportunity for us to join forces with the blood cancer community to raise awareness around these conditions.

Too often, due to the vagueness of blood cancer’s symptoms,1,2 diagnosis may be delayed. Increasing awareness around the symptoms of blood cancer is therefore critical, especially as certain forms of the condition can progress very quickly.3

Blood cancer in the UK

There are three types of blood cancer:4



A cancer which starts in blood-forming tissue, usually the bone marrow, and it leads to the over-production of abnormal white blood cells



A cancer that starts in the lymph glands or other organs of the lymphatic system.



A cancer of the bone marrow which affects the plasma cells.

Blood cancer is the fifth most common cancer type in the UK,4 with the median age of diagnosis being 70.9 years old.8  Each year around 40,000 people in the UK receive a blood cancer diagnosis,4 with this number set to increase as the result of an ageing population.9


A vision for the future

Blood cancer remains an urgent problem and it is important to continue to develop effective treatments for this group of diseases. At Pfizer, we are committed to prioritising patients’ needs in our continued research and development and doing our part for the blood cancer community. This Blood Cancer Awareness Month is an important step towards ensuring those affected by blood cancer can better recognise the symptoms and benefit from potentially lifesaving and life changing innovations.



  1. Cancer Research UK. Acute Lymphoblastic Leukaemia. Symptoms. Available at: Last Accessed: September 2018
  2. Cancer Research UK. Acute Myeloid Leukaemia. Symptoms. Available at: Last Accessed: September 2018
  3. NHS Choices. Acute myeloid leukaemia – overview. Available at: Last Accessed: September 2018
  4. Bloodwise. Facts and information about blood cancer. Available at: Last Accessed: September 2018
  5. Leukaemia Care. Leukaemia. Available at: Last Accessed: September 2018
  6. Leukaemia Care. Lymphoma. Available at: Last Accessed: September 2018
  7. Leukaemia Care. Myeloma. Available at: Last Accessed: September 2018
  8. Smith A, Howell D, Crouch S, et al. Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort. Int J Epidemiol. 2018;4 7(3):700-g
  9. Hassan M, Abedi-Valugerdi M. Hematologic malignancies in elderly patients. Haematologica. 2013, 1124-1127


PP-ONC-GBR-0692 / Sept 2018